Angel One - Share Market Trading and Stock Broking
LoginOpen Demat Account
Skip to main content
Neurocrine Biosciences Inc logo

Neurocrine Biosciences Inc Share Price

NASDAQ: NBIXHealthcare

$142.11

+0.62 (0.44%)
BUYSELL

Live Neurocrine Biosciences Inc Share Price Chart

O H L

Neurocrine Biosciences Inc Performance Overview

Days Range
▼
$140.50Low
$144.55High

Markets Today

Previous Close$140.71
Open$141.49
Volume1,638,337
Day's Range$140.50 - $144.55
52W Range$122.14 - $186.12
Market Cap$14.30 B

Historical Performance

1M Returns-9.58
3M Returns-17.84
6M Returns+8.80
1Y Returns+4.49
5Y Returns+42.04
10Y Returns+185.39

Neurocrine Biosciences Inc Fundamentals

Market Cap$14.30 B
Dividend yield0.00
PE Ratio20.63
PEG RatioN/A
Revenue$2.86 B
ROE TTM0.16
EPS TTM$6.82
Quarterly Earnings Growth YOYN/A
PB Ratio3.87
EBITDA$666.60 M
Profit Margin16.73
Market Cap$14.30 B
Dividend yield0.00
PE Ratio20.63
PEG RatioN/A
Revenue$2.86 B
ROE TTM0.16
EPS TTM$6.82
Quarterly Earnings Growth YOYN/A
PB Ratio3.87
EBITDA$666.60 M
Profit Margin16.73

Neurocrine Biosciences Inc Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$572.60 M$687.50 M$794.90 M$805.50 M$814.50 M$959.00 M
Gross Profit +$563.40 M$677.20 M$780.90 M$787.90 M$800.70 M$935.80 M
Operating Income $23.60 M$145.60 M$239.00 M$210.90 M$164.80 M$151.50 M
EBITDA $31.30 M$150.90 M$247.00 M$235.40 M$193.30 M$161.30 M
Interest Expense $0$0$0$0$0-$2.90 M
Depreciation $7.70 M$5.30 M$8.00 M$24.50 M$28.50 M$9.80 M
Income Before Tax $14.70 M$159.50 M$291.80 M$239.40 M$246.80 M$162.20 M
Income Tax Expense $6.80 M$52.00 M$82.30 M$85.70 M$48.90 M$17.80 M
Net Income +$7.90 M$107.50 M$209.50 M$153.70 M$197.90 M$144.40 M
Net Profit Margin 1.38%15.64%26.36%19.08%24.3%15.06%

Neurocrine Biosciences Inc Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $100.00 K$100.00 K$100.00 K$100.00 K$100.00 K$100.00 K
Reserve & Surplus $3.70 M$97.00 M$307.20 M$460.80 M$590.00 M$729.10 M
Non-Current Liabilities $629.10 M$649.20 M$624.10 M$635.00 M$667.10 M$791.00 M
Current Liabilities $522.90 M$546.30 M$638.00 M$743.40 M$831.70 M$874.50 M
Total Liabilities $1.15 B$1.20 B$1.26 B$1.38 B$1.50 B$1.67 B
Fixed Assets $123.40 M$128.90 M$133.00 M$94.50 M$90.90 M$2.32 B
Current Assets $1.64 B$1.75 B$2.16 B$2.52 B$2.44 B$1.64 B
Total Assets $3.69 B$3.89 B$4.27 B$4.63 B$4.91 B$5.36 B

Neurocrine Biosciences Inc Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income $7.90 M$107.50 M$209.50 M$153.70 M$197.90 M$144.40 M
Operating Cash Flow $64.80 M$102.00 M$227.50 M$388.40 M$145.80 M$136.40 M
Investing Cash Flow $14.20 M-$29.00 M-$196.70 M-$52.90 M-$506.20 M-$135.40 M
Financing Cash Flow -$117.90 M-$3.30 M$45.60 M$37.30 M-$86.10 M$63.40 M
Change in Cash -$38.90 M$69.90 M$76.20 M$372.80 M-$446.50 M$64.40 M

Neurocrine Biosciences Inc Return Calculator

The Neurocrine Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$14,098
Invested Amount$10,000
Est. Returns$4,098
Invest in USA Stock Today

About Neurocrine Biosciences Inc

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

FAQs

Neurocrine Biosciences Inc (NBIX) share price as of October 3, 2026 is $142.11. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Neurocrine Biosciences Inc (NBIX) Share by opening an international trading account with Angel One.
Purchasing Neurocrine Biosciences Inc (NBIX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Neurocrine Biosciences Inc (NBIX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Neurocrine Biosciences Inc (NBIX) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Neurocrine Biosciences Inc on October 3, 2026, is $14.30 B.
Neurocrine Biosciences Inc operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Neurocrine Biosciences Inc (NBIX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Want to open an NRI account?
Top US Stocks

VIEW ALL